Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)
52.70
+0.20 (0.38%)
Aug 17, 2026, 11:37 AM CET
BIT:REC Revenue
Recordati Industria Chimica e Farmaceutica had revenue of 697.36M EUR in the quarter ending June 30, 2026, with 8.30% growth. This brings the company's revenue in the last twelve months to 2.71B, up 9.10% year-over-year. In the year 2025, Recordati Industria Chimica e Farmaceutica had annual revenue of 2.62B with 11.82% growth.
Revenue (ttm)
2.71B
Revenue Growth
+9.10%
P/S Ratio
3.97
Revenue / Employee
581.29K
Employees
4,693
Market Cap
10.75B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.62B | 276.82M | 11.82% |
| Dec 31, 2024 | 2.34B | 259.23M | 12.45% |
| Dec 31, 2023 | 2.08B | 229.02M | 12.36% |
| Dec 31, 2022 | 1.85B | 273.23M | 17.29% |
| Dec 31, 2021 | 1.58B | 131.21M | 9.06% |
| Dec 31, 2020 | 1.45B | -32.98M | -2.23% |
| Dec 31, 2019 | 1.48B | 129.61M | 9.59% |
| Dec 31, 2018 | 1.35B | 64.11M | 4.98% |
| Dec 31, 2017 | 1.29B | 134.18M | 11.63% |
| Dec 31, 2016 | 1.15B | 106.27M | 10.14% |
| Dec 31, 2015 | 1.05B | 60.32M | 6.11% |
| Dec 31, 2014 | 987.36M | 45.73M | 4.86% |
| Dec 31, 2013 | 941.63M | 113.31M | 13.68% |
| Dec 31, 2012 | 828.32M | 66.28M | 8.70% |
| Dec 31, 2011 | 762.04M | 33.90M | 4.66% |
| Dec 31, 2010 | 728.13M | -19.39M | -2.59% |
| Dec 31, 2009 | 747.52M | 57.89M | 8.39% |
| Dec 31, 2008 | 689.63M | 61.20M | 9.74% |
| Dec 31, 2007 | 628.44M | 52.25M | 9.07% |
| Dec 31, 2006 | 576.19M | 106.00K | 0.02% |
| Dec 31, 2005 | 576.08M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Amplifon | 2.40B |
| DiaSorin | 1.18B |
| Safilo Group | 957.72M |
| EL.En. | 595.51M |
| GPI S.p.A. | 546.18M |
| Garofalo Health Care | 489.26M |
| Philogen | 319.73M |
| Svas Biosana | 141.56M |
Recordati Industria Chimica e Farmaceutica News
- 18 days ago - Recordati Industria Chimica e Farmaceutica Earnings Call Transcript: Q2 2026 - Transcripts
- 18 days ago - Recordati Industria Chimica e Farmaceutica Earnings release: Q2 2026 - Filings
- 18 days ago - Recordati Industria Chimica e Farmaceutica Slides: Q2 2026 - Filings
- 18 days ago - Recordati Industria Chimica e Farmaceutica Quarterly report: Q2 2026 - Filings
- 19 days ago - Recordati Earnings Up In H1; Maintains FY26 Outlook - Nasdaq
- 19 days ago - Recordati first-half core profit rises 8.8% on rare diseases - Reuters
- 4 weeks ago - Italy's Recordati says board finds CVC, GBL offer 'fair' as independent directors dissent - Reuters
- 3 months ago - CVC, Groupe Bruxelles Lambert Make $12.5 Billion Bid to Take Recordati Private - WSJ